lobbying_activities: 2823601

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2823601	5cc8a662-6e58-4719-b9a5-6aa1639bf175	Q2	BURRELL INTERNATIONAL GROUP LLC	401103483	AVALO THERAPEUTICS	2022	second_quarter	MED	Medical Countermeasures Development of Therapeutics for COVID-19 and Rare Disease	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2022-07-18T11:37:24-04:00